Dr. Rene Crombie, PhD.
Oxford Who’s Who has inducted Dr. Rene Crombie into the highest Professional Distinction “Top Tier of Excellence Lifetime Achievement Recognition” due to her outstanding leadership in biomedical research. She brings a wealth of knowledge to this field displaying a passion in molecular biology, protein biochemistry, and evolutionary genetics with an emphasis on translational medicine. Dr. Crombie is one of few special honorees distinguished based on her professional accomplishments, academic achievements, years of service, and the credentials she has provided. Dr. Rene Crombie’s intense involvement in numerous biomedical settings served to hone an awareness of obstacles to translational medicine. Given projected decades of logarithmic HIV-1 infection, the ability to transform puzzles of data from laboratory findings directly into effective intervention remains foremost. Her focus has shifted from the details of the HIV-1 molecular virology, to a more comprehensive view of AIDS as one of the most complex global health threats ever faced.
“I‘ve spent more than three decades as a bench scientist,” said Dr. Crombie who has been following the HIV / AIDS epidemic from its inception. She considers her work in AIDS research a personal journey having witnessed many friends die from the disease. As an AIDS researcher, Dr. Crombie contends there is still much work to do to contain a disease of such a complex nature. Although many strides have been made, there remains a void in the knowledge necessary for a high efficacy vaccine solution due to the genetic variations in differing populations worldwide. PRISMARC, Pilling-Robinson Integrated Systemic Microbicides and AIDS Research Collaborative, is focused on providing individually tailored guidance with the highest levels of scientific integrity to solve the paradoxes of AIDS illness and HIV-1 transmission. To honor her mission to eradicate AIDS illness and HIV-1, Dr. Crombie continues to keep pace with the exciting challenges that accompany the eradication of AIDS and HIV-1. According to Dr. Crombie, PRISMARC's ideal is to benefit others with untapped experience that dates back to the beginning of the AIDS era. She seeks to provide a new generation of scientists with valuable insights into what already is known about the progression of HIV-1 infection to the complications of AIDS. PRISMARC aims to reach an audience of students, post-doctoral fellows and early career Principal Investigators eager to excel beyond current understanding by exploring new avenues of study. PRISMARC's intent is to raise awareness of unmet challenges in the decades-long quest to control the HIV/AIDS epidemic worldwide. The PRISMARC hope is to accelerate viable approaches by exposing the numerous Over looked paradoxes in the field. PRISMARC is directed toward merging Basic Bioscience with a Clinical perspective, and at the same time highlight the Public Health dilemmas facing effective protection and treatment for all. Evolutionary Genetics with emphasis on Translational Medicine. PRISMARC will put the Art of Science back into your portfolio using expert data mining techniques!The specialized interest of PRISMARC's unique Proposal Network lies with natural HIV-1 inhibitory factors nascent in salivary secretions (1), vaginal fluids, and across the placental barrier. However, this DOES NOT LIMIT the scope of directions which are being pursued... wherever the data may lead, because AIDS is not just about HIV.It covers all aspects of HIV-1 biology, patho-pysiology, immune function, auxiliary binding receptors, vaccine evasion mechanisms, geographic Clade specificity, molecular mimicry, opportunistic infection eradication, and unexplained therapeutic phenomena... even Ebola homolo!